Next Article in Journal
The Versatility of the Roskamp Homologation in Synthesis
Previous Article in Journal
Mechanistic Study of L-Rhamnose Monohydrate Dehydration Using Terahertz Spectroscopy and Density Functional Theory
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 30
Issue 6
10.3390/molecules30061190
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Molecules 2022, 27(13), 4315.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315

by
Vivek P. Chavda
1,*,
Jinal Ajabiya
2,
Divya Teli
3,
Joanna Bojarska
4,*,† and
Vasso Apostolopoulos
5,6,*,†
1
Department of Pharmaceutics and Pharmaceutical Technology, LM College of Pharmacy, Ahmedabad 380009, India
2
Department of Pharmaceutics Analysis and Quality Assurance, LM College of Pharmacy, Ahmedabad 380009, India
3
Department of Pharmaceutical Chemistry, LM College of Pharmacy, Ahmedabad 380009, India
4
Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, 116 Żeromskiego Street, 90-924 Lodz, Poland
5
Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia
6
Australian Institute for Musculoskeletal Science (AIMSS), Immunology Program, Melbourne, VIC 3030, Australia
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Molecules 2025, 30(6), 1190; https://doi.org/10.3390/molecules30061190
Submission received: 24 February 2025 / Accepted: 26 February 2025 / Published: 7 March 2025
(This article belongs to the Section Medicinal Chemistry)
Versions Notes

Citation Correction

There was an error in the original paper [1] related to the order of citations. Reference Citations 55 and 56 were intended for the Introduction, not the main text. The authors decided to remove these citations to avoid confusion. The remaining citations were renumbered and ordered in the manuscript.
The authors apologize for any confusion this may have caused. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Chavda, V.P.; Ajabiya, J.; Teli, D.; Bojarska, J.; Apostolopoulos, V. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chavda, V.P.; Ajabiya, J.; Teli, D.; Bojarska, J.; Apostolopoulos, V. Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315. Molecules 2025, 30, 1190. https://doi.org/10.3390/molecules30061190

AMA Style

Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V. Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315. Molecules. 2025; 30(6):1190. https://doi.org/10.3390/molecules30061190

Chicago/Turabian Style

Chavda, Vivek P., Jinal Ajabiya, Divya Teli, Joanna Bojarska, and Vasso Apostolopoulos. 2025. "Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315" Molecules 30, no. 6: 1190. https://doi.org/10.3390/molecules30061190

APA Style

Chavda, V. P., Ajabiya, J., Teli, D., Bojarska, J., & Apostolopoulos, V. (2025). Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315. Molecules, 30(6), 1190. https://doi.org/10.3390/molecules30061190

Article Metrics

Back to TopTop